Editas Medicine Inc (EDIT) Insider Trading
- $2,896,814.00
- $51,420,440.12
- March 3, 2026
- Katrine Bosley
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 12, 2021 | CFO | 1,568 | $78.27 | Sell | $122,727.36 | |
| Dec. 15, 2020 | EVP | 10,000 | $63.22 | Sell | $632,200.00 | |
| Dec. 9, 2020 | EVP | 10,000 | $45.00 | Sell | $450,000.00 | |
| Dec. 7, 2020 | EVP | 20,000 | $40.02 | Sell | $800,400.00 | |
| Oct. 15, 2020 | EVP | 3,000 | $31.39 | Sell | $94,170.00 | |
| Aug. 20, 2020 | CEO | 1,976 | $36.66 | Sell | $72,440.16 | |
| Aug. 17, 2020 | EVP | 10,000 | $35.29 | Sell | $352,900.00 | |
| July 15, 2020 | EVP | 3,000 | $32.22 | Sell | $96,660.00 | |
| Feb. 3, 2020 | Insider | 5,549 | $26.54 | Sell | $147,270.46 | |
| Aug. 19, 2019 | CEO | 5,193 | $25.83 | Sell | $134,135.19 | |
| March 18, 2019 | Insider | 3,000 | $24.50 | Sell | $73,500.00 | |
| March 5, 2019 | Director | 10,200 | $23.94 | Buy | $244,188.00 | |
| Feb. 20, 2019 | Insider | 3,000 | $20.42 | Sell | $61,260.00 | |
| Feb. 4, 2019 | CFO | 6,895 | $21.39 | Sell | $147,484.05 | |
| Jan. 18, 2019 | Insider | 7,000 | $26.36 | Sell | $184,520.00 | |
| Jan. 8, 2019 | CEO | 12,000 | $25.27 | Sell | $303,240.00 | |
| Jan. 4, 2019 | CFO | 7,000 | $22.48 | Sell | $157,360.00 | |
| Dec. 18, 2018 | Insider | 7,000 | $27.61 | Sell | $193,270.00 | |
| Dec. 3, 2018 | CEO | 12,000 | $31.92 | Sell | $383,040.00 | |
| Nov. 23, 2018 | CFO | 5,284 | $28.15 | Sell | $148,744.60 | |
| Nov. 20, 2018 | CTO | 4,000 | $26.50 | Sell | $106,000.00 | |
| Nov. 1, 2018 | Insider | 12,000 | $26.88 | Sell | $322,560.00 | |
| Oct. 26, 2018 | CFO | 6,000 | $25.70 | Sell | $154,200.00 | |
| Oct. 18, 2018 | CTO | 4,000 | $29.44 | Sell | $117,760.00 | |
| Oct. 1, 2018 | CEO | 12,000 | $31.02 | Sell | $372,240.00 | |
| Sept. 28, 2018 | CFO | 8,000 | $32.08 | Sell | $256,640.00 | |
| Sept. 17, 2018 | CTO | 3,000 | $32.33 | Sell | $96,990.00 | |
| Sept. 4, 2018 | CEO | 12,000 | $32.35 | Sell | $388,200.00 | |
| Aug. 31, 2018 | CFO | 10,000 | $32.23 | Sell | $322,300.00 | |
| Aug. 20, 2018 | CEO | 12,000 | $30.17 | Sell | $362,040.00 | |
| Aug. 20, 2018 | CTO | 4,000 | $29.87 | Sell | $119,480.00 | |
| Aug. 17, 2018 | CTO | 3,000 | $29.65 | Sell | $88,950.00 | |
| Aug. 1, 2018 | Insider | 8,333 | $29.55 | Sell | $246,240.15 | |
| July 18, 2018 | Insider | 14,000 | $35.63 | Sell | $498,820.00 | |
| July 2, 2018 | Insider | 8,333 | $36.29 | Sell | $302,404.57 | |
| June 19, 2018 | Insider | 14,000 | $38.26 | Sell | $535,640.00 | |
| June 13, 2018 | Insider | 10,000 | $35.98 | Sell | $359,800.00 | |
| June 4, 2018 | CFO | 10,000 | $38.63 | Sell | $386,300.00 | |
| June 1, 2018 | Insider | 8,333 | $37.55 | Sell | $312,904.15 | |
| May 23, 2018 | Insider | 10,000 | $35.00 | Sell | $350,000.00 | |
| May 17, 2018 | Director | 6,700 | $37.28 | Buy | $249,776.00 | |
| May 1, 2018 | Insider | 8,333 | $31.95 | Sell | $266,239.35 | |
| April 2, 2018 | Insider | 8,333 | $32.16 | Sell | $267,989.28 | |
| March 20, 2018 | CFO | 40,000 | $38.06 | Sell | $1,522,400.00 | |
| March 16, 2018 | CFO | 6,000 | $39.43 | Sell | $236,580.00 | |
| March 9, 2018 | Insider | 9,134 | $45.00 | Sell | $411,030.00 | |
| March 1, 2018 | Insider | 8,333 | $35.72 | Sell | $297,654.76 | |
| Feb. 16, 2018 | CFO | 18,000 | $34.21 | Sell | $615,780.00 | |
| Feb. 1, 2018 | CEO | 8,333 | $36.18 | Sell | $301,487.94 | |
| Jan. 30, 2018 | Insider | 20,000 | $38.79 | Sell | $775,800.00 |
Insiders are both buying and selling Editas Medicine Inc stock.
The insider traders at Editas Medicine Inc are: Katrine Bosley, Bruce Eaton, Andrew A F Hack, Vickesh Myer, Charles Albright, Michelle Robertson, Gilmore Neil O'neill, Baisong Mei, Linda Burkly, Kevin Bitterman, Alexandra Glucksmann, Amy Parison, Jessica Hopfield, Polaris Venture Management Co., Mark S Shearman, Cynthia Collins, Gerald Frank Cox, Lisa Anne Michaels, Boris Nikolic, James C Mullen, James E Flynn, and Kevin P. Starr
The most active insider trader at Editas Medicine Inc is Katrine Bosley with 23 trades.
Kevin Bitterman has sold the most Editas Medicine Inc stock with a total value of $37,897,894.80.
James E Flynn has bought the most Editas Medicine Inc stock with a total value of $3,200,000.00.
The most recent insider trade for Editas Medicine Inc was on March 3, 2026.
The single biggest insider buy for Editas Medicine Inc was from James E Flynn with a total value of $1,600,000.00 on Feb. 8, 2016.
The single biggest insider sell for Editas Medicine Inc was from Kevin Bitterman with a total value of $17,000,000.00 on May 22, 2017.
